CELLECTISAct. Nom. Aktie
| 3,01EUR | -0,01EUR | -0,17% |
WKN DE: A0MKPR / ISIN: FR0010425595
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 294 | 237 | 221 | 222 | 229 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,16 | 0,08 | 0,00 | 0,17 | 0,28 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 198 | 114 | 211 | 277 | 201 |
| Summe Anlagevermögen | 138 | 130 | 92 | 102 | 75 |
| Summe Aktiva | 336 | 245 | 303 | 379 | 276 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 128 | 127 | 226 | 253 | 212 |
| Summe Eigenkapital | 208 | 118 | 77 | 127 | 65 |
| Summe Passiva | 336 | 245 | 303 | 379 | 276 |
Adresse
| 8, rue de la Croix Jarry, 75013 Paris | |
| Telefon | +33 (1) 81-69-16-00 |
| Fax | +33 (1) 81-69-16-06 |
| Internet | http://www.cellectis.com |
Management
|
Adrian Kilcoyne
Chief Medical Officer |
|
André C. Muller
Independent Director |
|
André Choulika
Chief Executive Officer & Director |
|
Arthur Stril
Chief Financial & Business Officer |
|
Cécile Chartier
Director |
|
David J. Sourdive
Director & Executive VP-CMC & Manufacturing |
|
Donald A. Bergstrom
Independent Director |
|
Jean-Pierre Garnier
Non-Executive Chairman |
|
Kyung Nam-Wortman
Chief Human Resources Officer & Executive VP |
|
Laurent Arthaud
Independent Director |
|
Marc Pierre Jean Dunoyer
Director |
|
Marie-Bleuenn Terrier
Secretary & General Counsel |
|
Philippe Duchateau
Chief Scientific Officer |
|
Rainer J. Boehm
Independent Director |
|
Stephan Reynier
Chief Regulatory & Compliance Officer |
|
Steve Doares
Senior Vice President-US Manufacturing |
|
Tyrell J. Rivers
Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.